<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Health / Medical research / Pharmacovigilance / European Medicines Agency / EudraLex / European Directive on Traditional Herbal Medicinal Products / Postmarketing surveillance / Adverse effect / Qualified Person Responsible For Pharmacovigilance / EudraVigilance
Date: 2015-11-08 06:14:30
Pharmaceuticals policy
Health
Medical research
Pharmacovigilance
European Medicines Agency
EudraLex
European Directive on Traditional Herbal Medicinal Products
Postmarketing surveillance
Adverse effect
Qualified Person Responsible For Pharmacovigilance
EudraVigilance

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

Add to Reading List

Source URL: www.myereport.eu

Download Document from Source Website

File Size: 386,06 KB

Share Document on Facebook

Similar Documents

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

DocID: 1rcFm - View Document

COMMISSION OF THE EUROPEAN COMMUNITIES  Brussels, 10 December 2008 SECVolume I

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

DocID: 1qH6O - View Document

Better vigilance for health health protection protection and and innovation

Better vigilance for health health protection protection and and innovation

DocID: 1q6Mb - View Document

Microsoft Word - Volume IX ENdoc

Microsoft Word - Volume IX ENdoc

DocID: 1g2y9 - View Document

Pharmacology / Health / Notary / Drug safety / Qualified Person Responsible For Pharmacovigilance / Marketing authorization / Pharmacovigilance / Public key certificate / Pharmaceuticals policy / Pharmaceutical sciences / Pharmaceutical industry

Name of medicinal product: Procedure number: Module 1: PL=RMS

DocID: 1fB8i - View Document